Skip to main content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

An International Journal for Oncology and Haematology Professionals

memo - Magazine of European Medical Oncology OnlineFirst articles

02.12.2021 | Congress Report WCLC 2021 – ESMO 2021

Report from the virtual World Conference on Lung Cancer, 8th –14th September 2021, and the virtual ESMO Congress, 16th –21st September, 2021

24.11.2021 | short review Open Access

Clinical challenges in the management of endocrine side effects of immuno-oncological therapies

Given the growing use of immune checkpoint inhibitor (ICI) therapy in oncology, the prevalence of endocrine side effects is rapidly increasing. As clinicians are nowadays frequently confronted with these side effects in routine clinical care …

22.11.2021 | original report

Clinical characteristics and prognostic value of 1q21 gain detected by fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma

Multiple myeloma (MM) is a malignant B‑cell disorder characterized by heterogeneous cytogenetic abnormalities, resulting in a wide heterogeneity in survival outcomes [ 1 , 2 ]. Although treatment strategies for MM have improved in the last decade …

08.11.2021 | short review Open Access

The value of immunotherapy in pediatric leukemia and lymphoma

Leukemia and lymphoma are a leading cause of cancer-related mortality in children and the prognosis for patients with relapsed or refractory disease remains poor. Standard therapies are associated with a wide array of acute and long-term …

04.11.2021 | short review Open Access

Cardiotoxicity—current recommendations of prevention and treatment

Tremendous advances in modern oncology therapies enable an increasing life expectancy of many cancer entities. Short or long-term cardiovascular side effects, however, gain importance. The current review focuses on recent recommendations for …

Aktuelle Ausgaben

Über diese Zeitschrift

The focus of the journal "magazine of european medical oncology – memo" is to offer a professional review on current research and development in the field of hematology and oncology relevant for daily practice. Therefore, memo includes editorials and comments, peer-reviewed original reports, short reviews, case reports and controversies, articles explaining the biology of neoplasia and congress reports including qualified comments. As a European journal memo aims at highlighting the local peculiarities of various regions and at being a forum for the presentation of ongoing clinical and basic research.

memo is the Official Journal of the Central European Cooperative Oncology Group (CECOG) and The Austrian Society of Haematology and Oncology (OeGHO).

Weitere Informationen